This is a Validated Antibody Database (VAD) review about human PAR-2, based on 18 published articles (read how Labome selects the articles), using PAR-2 antibody in all methods. It is aimed to help Labome visitors find the most suited PAR-2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PAR-2 synonym: GPR11; PAR2
Knockout validation
Invitrogen mouse monoclonal (SAM11) |
| In order to test if proteinase-activated receptor-2 modulates the deleterious effects of IL-1beta in ischemic retinopathies, Invitrogen PAR-2 antibody (Invitrogen, clone SAM11) was used in western blot knockout validation on mouse samples at 1:400 (fig 1) and in immunohistochemistry on mouse samples at 1:500 (fig 1). Am J Pathol (2015) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (Santa Cruz Biotechnology, sc-13504) was used in immunohistochemistry on human samples at 1:50 (fig 4a). Cancers (Basel) (2021) ncbi |
mouse monoclonal |
| Santa Cruz Biotechnology PAR-2 antibody (SantaCruz, SAM11) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a) and in western blot on human samples (fig 1c). Oncotarget (2017) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (SantaCruz, SAM11) was used in western blot on human samples (fig 1c) and in immunohistochemistry - paraffin section on mouse samples (fig 7a). Oncotarget (2017) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (Santa Cruz, sc-13504) was used in western blot on human samples (fig 2b). Front Pharmacol (2016) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (santa cruz, sc-13504) was used in flow cytometry on human samples at 1:100 (fig 2 b-e), in immunohistochemistry on human samples (fig 1a) and in western blot on human samples at 1:100 (fig 2). J Biol Chem (2016) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (Santa Cruz, sc-13504) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2015) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (Santa Cruz, sc-13504) was used in flow cytometry on human samples (fig 2) and in immunocytochemistry on human samples (fig 2). Physiol Rep (2015) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (Santa Cruz, sc-13504) was used in western blot on human samples at 1:1000 (fig 1b). Cell Death Dis (2014) ncbi |
mouse monoclonal (SAM11) |
| Santa Cruz Biotechnology PAR-2 antibody (Santa Cruz Biotechnology, SC-13504) was used in immunohistochemistry on mouse samples at 1:250 and in immunohistochemistry on rat samples at 1:250. J Comp Neurol (2009) ncbi |
Invitrogen
mouse monoclonal (SAM11) |
| In order to assess the effect of polyinosinic-polycytidylic acid on the barrier function and tight junction integrity of primary human lung microvascular endothelial cells, Invitrogen PAR-2 antibody (Invitrogen, 35-2300) was used in immunocytochemistry on human samples (fig 4). PLoS ONE (2016) ncbi |
mouse monoclonal (SAM11) |
| Invitrogen PAR-2 antibody (Zymed Laboratories, SAM11) was used in immunohistochemistry - paraffin section on human samples , in immunocytochemistry on human samples and in western blot on human samples at 1:100. Hum Pathol (2015) ncbi |
mouse monoclonal (SAM11) |
| In order to test if proteinase-activated receptor-2 modulates the deleterious effects of IL-1beta in ischemic retinopathies, Invitrogen PAR-2 antibody (Invitrogen, clone SAM11) was used in western blot knockout validation on mouse samples at 1:400 (fig 1) and in immunohistochemistry on mouse samples at 1:500 (fig 1). Am J Pathol (2015) ncbi |
mouse monoclonal (SAM11) |
| In order to examine expression and biological activity of PAR-1 and PAR-2 in normal and pathological cutaneous scars, Invitrogen PAR-2 antibody (Zymed, clone SAM11) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Pathol (2007) ncbi |
mouse monoclonal (SAM11) |
| In order to determine the expression of PAR-1, PAR-2, MMP-2, MMP-9, COX-1, and COX-2 in patients with orofacial granulomatosis, Invitrogen PAR-2 antibody (Zymed, SAM 11) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Oral Dis (2007) ncbi |
mouse monoclonal (SAM11) |
| In order to look for a cellular receptor for Bacteroides fragilis toxin on intestinal epithelial cells, Invitrogen PAR-2 antibody (Zymed, SAM11) was used in immunocytochemistry on human samples (fig 4). Infect Immun (2006) ncbi |
Abcam
domestic rabbit monoclonal (EPR13675) |
| Abcam PAR-2 antibody (Abcam, ab180953) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 1a) and in western blot on rat samples (fig 1c). Aging (Albany NY) (2019) ncbi |
domestic rabbit polyclonal |
| Abcam PAR-2 antibody (Abcam, ab124227) was used in western blot on human samples (fig 4b). Mol Syst Biol (2017) ncbi |
LifeSpan Biosciences
mouse monoclonal (SAM11) |
| LifeSpan Biosciences PAR-2 antibody (LSBio, SAM11) was used in immunohistochemistry on mouse samples , in western blot on mouse samples and in immunohistochemistry on human samples (fig 1a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi |
Cell Signaling Technology
domestic rabbit monoclonal (D61D5) |
| Cell Signaling Technology PAR-2 antibody (Cell Signaling, 6976) was used in western blot on rat samples at 1:1000 (fig 5a). Biosci Rep (2020) ncbi |
Articles Reviewed
- Materazzi S, Pellerito S, Di Serio C, Paglierani M, Naldini A, Ardinghi C, et al. Analysis of protease-activated receptor-1 and -2 in human scar formation. J Pathol. 2007;212:440-9 pubmed
- Ketabchi S, Massi D, Ficarra G, Rubino I, Franchi A, Paglierani M, et al. Expression of protease-activated receptor-1 and -2 in orofacial granulomatosis. Oral Dis. 2007;13:419-25 pubmed
- Wu S, Shin J, Zhang G, Cohen M, Franco A, Sears C. The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect Immun. 2006;74:5382-90 pubmed
articles
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments